Dengue virus serological markers among potential blood donors: an evidence of asymptomatic dengue virus transmission in Cameroon
- PMID: 32952829
- PMCID: PMC7467628
- DOI: 10.11604/pamj.2020.36.185.22128
Dengue virus serological markers among potential blood donors: an evidence of asymptomatic dengue virus transmission in Cameroon
Abstract
Introduction: the risk of dengue virus or its antibodies which can be transmitted through blood transfusion by asymptomatic individuals infected, has been a major concern all over the world. Dengue is an endemic disease in sub-Saharan Africa, particularly in Cameroon. The purpose of this study is to determine the frequency of dengue virus (DENV) infection among potential blood donors at Yaounde Jamot Hospital.
Methods: serum samples were collected from 310 potential adult blood donors aged 18-57 years, who signed a written informed consent and completed the questionnaire between March 2019 and August 2019. This serum is used to screen for the presence of serological markers of DENV infection (NS1, IgM and IgG) using immunochromatographic tests (Zhuhai Encode Medical Engineering Co., Ltd, China). IgM/IgG positive samples were confirmed by enzyme-linked immunosorbent assays (ELISA).
Results: the overall prevalence was 24.8% among potential blood donors were subdivided as follows: 4.5% (14/310), 12.3% (38/310) and 6.1% (19/310) showed mono-positivity to DENV-NS1 antigen, anti-DENV IgM and anti-DENV IgG antibodies respectively. 1.9% (6/310) of potential blood donors showed dual positivity to anti-DENV IgM antibodies and anti-DENV IgG antibodies. The presence of DENV-NS1 antigen show asymptomatic viremia of dengue at the time of donation, while the presence of IgG antibodies reflects the high endemicity of dengue disease in the city of Yaoundé.
Conclusion: these findings demonstrate the high level of risk of the DENV transmission among potential blood donors to needy recipients, underscoring the importance of establishing dengue fever blood screening in different services and blood collection units in Cameroon to improve safety transfusion and control the dissemination of the DENV.
Keywords: Cameroon; Dengue fever; potential blood donors; seroprevalence.
Copyright: Salomon Bonsi Tchuandom et al.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].Mikrobiyol Bul. 2010 Jul;44(3):415-24. Mikrobiyol Bul. 2010. PMID: 21063991 Turkish.
-
Dengue virus transmission risk in blood donation: Evidence from Thailand.J Med Virol. 2024 Jun;96(6):e29689. doi: 10.1002/jmv.29689. J Med Virol. 2024. PMID: 38818789
-
Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province.BMC Infect Dis. 2021 Jan 22;21(1):104. doi: 10.1186/s12879-021-05810-8. BMC Infect Dis. 2021. PMID: 33482756 Free PMC article.
-
Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review.Braz J Infect Dis. 2018 Jan-Feb;22(1):63-69. doi: 10.1016/j.bjid.2018.01.001. Epub 2018 Jan 19. Braz J Infect Dis. 2018. PMID: 29353669 Free PMC article. Review.
-
Dengue Detection: Advances in Diagnostic Tools from Conventional Technology to Point of Care.Biosensors (Basel). 2021 Jun 23;11(7):206. doi: 10.3390/bios11070206. Biosensors (Basel). 2021. PMID: 34201849 Free PMC article. Review.
Cited by
-
An update on the mosquito fauna and mosquito-borne diseases distribution in Cameroon.Parasit Vectors. 2021 Oct 11;14(1):527. doi: 10.1186/s13071-021-04950-9. Parasit Vectors. 2021. PMID: 34635176 Free PMC article. Review.
References
-
- Karim F, Nasir N, Moiz B. Transfusion transmitted dengue: one donor infects two patients. Transfus Apher Sci. 2017 Apr;56(2):151–3. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical